HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
Deals & M&A

What is the difference between M&A and licensing deals?

In an M&A transaction, one company acquires another entirely, gaining all assets, liabilities, and pipeline. In a licensing deal, one company pays for rights to a specific asset (usually a drug or platform technology) while both companies remain independent. Licensing deals typically involve upfront payments plus milestone-based payments and royalties.